SCHEMBL17346336

SCHEMBL17346336

c1ccc(CSCCCNCCCN(Cc2ccccc2)C2CCCCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.43
SIGMAR1 Q99720 2/20 0.42
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LTA4H P09960 2/20 0.38
CXCR4 P61073 2/20 0.37
REN P00797 1/20 0.37
RAB9A P51151 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
G6PC1 P35575 1/20 0.36
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
CXCL12 P48061 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346343 0.99 ACKR3 (0.44) ACKR3SIGMAR1KMT2AMEN1ALDH1A1
SCHEMBL17346152 0.89 GRIN2B (0.40) ACKR3SIGMAR1KMT2ADRD2DRD4
SCHEMBL17346415 0.88 SIGMAR1 (0.43) ACKR3SIGMAR1LTA4HCXCR4RAB9A
SCHEMBL17346185 0.88 DRD3 (0.47) SIGMAR1KMT2ADRD2DRD4DRD3
SCHEMBL17346412 0.88 SIGMAR1 (0.43) ACKR3SIGMAR1LTA4HCXCR4RAB9A
SCHEMBL17346241 0.88 GRIN2B (0.41) ACKR3SIGMAR1KMT2ADRD2DRD4
SCHEMBL17346142 0.88 KMT2A (0.40) ACKR3SIGMAR1KMT2AMEN1ALDH1A1
SCHEMBL17346176 0.87 DRD3 (0.46) SIGMAR1KMT2AOPRM1OPRK1DRD2
SCHEMBL17346354 0.87 SIGMAR1 (0.41) ACKR3SIGMAR1OPRM1OPRK1DRD2
SCHEMBL17346132 0.86 KMT2A (0.40) ACKR3KMT2AMEN1ALDH1A1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN ACKR3 1678/4885SIGMAR1 412/4885KMT2A 4514/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN ACKR3 1678/4885SIGMAR1 412/4885KMT2A 4514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.